SCOTTS MIRACLE-GRO CO quarterly report, Q4 FY2012

Full document

Business context and reporting period

Scotts Miracle-Gro manufactures and markets lawn and garden products, operates Scotts LawnService, and acts as Monsanto’s exclusive agent for consumer Roundup products in specified markets. The filing text is internally inconsistent about the reporting period: its cover and several statements say September 30, 2012, while the August 9, 2012 signature and MD&A indicate results through June 30, 2012. The period therefore cannot be confirmed from this excerpt; figures below are reported as presented.

Financial performance and position

  • Revenue: The primary statement reports $401.2 million for the three-month period versus $403.1 million, and $2.826 billion for the nine-month period versus $2.800 billion.
  • Profit: Nine-month gross profit was $961.3 million versus $1.009 billion; operating income was $243.6 million versus $274.8 million. Net income was $106.5 million versus $167.9 million, and diluted EPS was $1.71 versus $2.54. For the three-month period, net loss was $39.5 million versus $53.3 million.
  • Margins: Nine-month gross margin declined to 34.0% from 36.0%. The three-month gross margin increased to 26.2% from 23.7%.
  • Cash flow and liquidity: The cash flow statement reports $115.1 million of operating cash flow versus cash used of $13.5 million, and ending cash of $132.3 million versus $164.3 million. The balance sheet reports current assets of $1.346 billion and current liabilities of $810.2 million.
  • Debt: Reported debt totaled $771.2 million, including $90.8 million current and $680.4 million long-term, versus $784.2 million in the comparative column. Revolver availability was reported at $1.4 billion; the company said it complied with debt covenants.
  • Shareholder returns: Nine-month dividends declared were $0.90 per share versus $0.75. The company announced an increase in the quarterly dividend from $0.30 to $0.325 per share.

Changes versus the prior comparable period

Nine-month revenue rose modestly, but operating income and net income declined. Management attributed pressure primarily to higher materials and distribution costs, increased advertising and selling investment, and higher interest expense. Sales growth was below expectations despite marketing support and holding customer prices flat. Share repurchases reduced the weighted-average share count.

Outlook, risks and unusual items

  • Management said fiscal 2012 operating income, previously expected to be relatively flat year over year, was now expected to decline versus fiscal 2011. It moderated near-term growth expectations and planned price increases to recover part of the decline; no quantified updated forecast is provided.
  • Product-registration matters remain significant. The company agreed to plead guilty to FIFRA violations, with a $4 million penalty and specified environmental contributions; sentencing was pending and EPA and state investigations continued. The company warned that additional penalties or claims could exceed its accrual.
  • Restructuring continued, and the company recorded a $5.3 million impairment related to product commercialization issues, including the active ingredient MAT 28.
  • Management cited seasonal concentration in the second and third fiscal quarters. It considered operating cash flows and available borrowing capacity sufficient for anticipated needs, while noting that cash generation and future credit availability are not assured.
  • Other exposures include environmental remediation, asbestos-related claims for which no loss estimate was considered reasonably possible, commodity and foreign-exchange risks, and dependence on the Monsanto Roundup marketing agreement.

Important facts for investors to verify

  1. Confirm the actual filing and reporting period: the excerpt combines September 30 dates with June 30 references and an August 9 signature.
  2. Reconcile reported revenue: the primary statement gives nine-month sales of $2.826 billion, while segment information gives consolidated sales of $2.873 billion.
  3. Reconcile cash-flow and income figures: the excerpt reports operating cash flow of $115.1 million in one statement but $153.4 million in consolidating information, and also contains differing net-income and ending-cash figures.
  4. Review the updated operating-income outlook, planned pricing actions, and the effect of input costs and advertising on margins.
  5. Track the FIFRA proceedings, final sentence, remaining accrual adequacy, and any additional regulatory or legal liabilities.